Aggrastat (tirofiban) is an antiplatelet medication that prevents blood clots from forming. It's used in certain situations to lower the risk of complications from blood clots that reach the heart for some people with serious heart conditions. Aggrastat (tirofiban) is given as a continuous infusion through the veins in the hospital, sometimes before a medical procedure to open clogged blood vessels known as percutaneous coronary intervention (PCI).
Lower the risk of heart-related problems (e.g., heart attack, death) from blood clots in adults with non-ST elevation acute coronary syndrome (NSTE-ACS)
Serious allergic reaction to Aggrastat (tirofiban)
History of low platelet count from previous Aggrastat (tirofiban) treatment
Internal bleeding, a history of bleeding episodes, or major surgery or injury in the past month
Lower the risk of heart-related problems (e.g., heart attack, death) from blood clots in adults with non-ST elevation acute coronary syndrome (NSTE-ACS)
Acute coronary syndrome (ACS), like heart attack or chest pain, in adults receiving medications for treatment
Adults getting a percutaneous coronary intervention (PCI, a procedure to open clogged blood vessels)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American Heart Association. (2020). What are anticoagulants and antiplatelet agents?
American Heart Association. (2023). Heart procedures and surgeries.
American Red Cross. (n.d.). Platelets and thrombocytopenia.
Amsterdam, E. A., (2014). 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation.
Chang, H., et al. (2012). Non–ST-segment elevation acute coronary syndromes. Circulation: Cardiovascular Imaging.
Hashemzadeh, M., et al. (2008). Chemical structures and mode of action of intravenous glycoprotein IIb/IIIa receptor blockers: A review. Experimental & Clinical Cardiology.
Medicure International Inc. (2023). Aggrastat- tirofiban injection, solution [package insert]. DailyMed.
National Heart, Lung, and Blood Institute. (2022). Thrombocytopenia.
National Heart, Lung, and Blood Institute. (2022). What is cardiac catheterization.
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. (1998). Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non–Q-wave myocardial infarction. The New England Journal of Medicine.
Sarkees, M. L., et al. (2010). Non ST-elevation acute coronary syndrome. British Medical Journal Clinical Evidence.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.